Lamivudine
- Product NDC
- 69967-004
- 11-digit product format
- 699670004
- Labeler code
- 69967
- Product ID
- 69967-004_859762e4-f76d-4241-96cd-c4dc670fb85f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- ARISE PHARMACEUTICALS LLC
- Application
- ANDA206974
- Marketing category
- ANDA
- Marketing start
- 2019-04-09
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record